With its partners, DNDi has developed four improved visceral leishmaniasis (VL) treatments, including two in 2022 alone, that have replaced more toxic treatments requiring long hospitalization. Through its long-term strategy, DNDi has replenished the R&D pipeline with an unprecedented portfolio of all-new potential drugs that could revolutionize treatment and accelerate progress towards global elimination goals.
Post-kala-azar dermal leishmaniasis (PKDL) is a complication of VL that appears as a rash or skin condition months or years after successful VL treatment. Although it is not deadly, it can be highly stigmatizing. Because PKDL can act as a reservoir for VL infection, early and effective PKDL treatment is critical to achieving sustained reductions in VL transmission. DNDi completed two Phase II studies in 2021, one testing liposomal amphotericin B (LAmB)+miltefosine (MF) and MF+paromomycin (PM) in Sudan, and one testing LAmB monotherapy and LAmB+MF in India and Bangladesh. With both trials bringing evidence for shorter, safer treatments to replace the current 60- to 90-day antimonial treatment in Sudan and 12-week miltefosine monotherapy treatment in South Asia, it is expected these alternative therapies will be recommended for patients with PKDL.
more_horiz
Sectors:
Health policy and administrative management
Sector code:
12110
- Health policy and administrative management
Sector vocabulary:
1
-
OECD DAC CRS Purpose Codes (5 digit)
Medical services
Sector code:
12191
- Medical services
Sector vocabulary:
1
-
OECD DAC CRS Purpose Codes (5 digit)
Basic health infrastructure
Sector code:
12230
- Basic health infrastructure
Sector vocabulary:
1
-
OECD DAC CRS Purpose Codes (5 digit)
Infectious disease control
Sector code:
12250
- Infectious disease control
Sector vocabulary:
1
-
OECD DAC CRS Purpose Codes (5 digit)
Health education
Sector code:
12261
- Health education
Sector vocabulary:
1
-
OECD DAC CRS Purpose Codes (5 digit)
Health personnel development
Sector code:
12281
- Health personnel development
Sector vocabulary:
1
-
OECD DAC CRS Purpose Codes (5 digit)
Health policy and administrative management
Sector code:
121
- Health policy and administrative management
Sector vocabulary:
2
-
OECD DAC CRS Purpose Codes (3 digit)
Basic health care
Sector code:
122
- Basic health care
Sector vocabulary:
2
-
OECD DAC CRS Purpose Codes (3 digit)
Sector code:
-
Sector vocabulary:
7
-
Sector code:
-
Sector vocabulary:
8
-
Sector code:
3.3.5 Number of people requiring interventions against neglected tropical diseases
-
Sector vocabulary:
9
-
Participating Organisations
Name
Type
Role
Drugs for Neglected Diseases initiative
Foundation
Funding
Transaction
Transaction Value
Provider
Receiver
Type
Date
23,913
EUR
(Valued at Dec 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
871
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
5,838
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
1,168
EUR
(Valued at Dec 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
1,664
EUR
(Valued at Dec 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
6,300
EUR
(Valued at Dec 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
3,785
EUR
(Valued at Dec 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
1,129
EUR
(Valued at Dec 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
595
EUR
(Valued at Dec 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
482
EUR
(Valued at Dec 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
1,424
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
379
EUR
(Valued at Dec 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
518
EUR
(Valued at Dec 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
4,771
EUR
(Valued at Dec 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
218,897
EUR
(Valued at Dec 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
51,989
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
101,971
EUR
(Valued at Dec 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
208,452
EUR
(Valued at Dec 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
12,392
EUR
(Valued at Dec 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
97,540
EUR
(Valued at Dec 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
1,920
EUR
(Valued at Dec 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
1,591
EUR
(Valued at Dec 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
5,400
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
12,836
EUR
(Valued at Dec 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
27,959
EUR
(Valued at Dec 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
98
EUR
(Valued at Dec 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
15,541
EUR
(Valued at Dec 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
24,871
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
22,130
EUR
(Valued at Dec 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
968
EUR
(Valued at Dec 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
25,587
EUR
(Valued at Dec 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
55,861
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
74
EUR
(Valued at Dec 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
2,000
EUR
(Valued at Dec 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
14,843
EUR
(Valued at Dec 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
1,200
EUR
(Valued at Dec 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
32,025
EUR
(Valued at Dec 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
4,314
EUR
(Valued at Dec 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
2,866
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
113,470
EUR
(Valued at Dec 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
45,581
EUR
(Valued at Dec 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
416
EUR
(Valued at Dec 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
62,534
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
2,005
EUR
(Valued at Dec 31, 2023)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
6,069
EUR
(Valued at Dec 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
94,577
EUR
(Valued at Dec 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
196,945
EUR
(Valued at Dec 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
75,947
EUR
(Valued at Dec 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
957
EUR
(Valued at Dec 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
87,268
EUR
(Valued at Dec 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
4,440
EUR
(Valued at Dec 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
4,416
EUR
(Valued at Dec 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
8,808
EUR
(Valued at Dec 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
1,685
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
4,451
EUR
(Valued at Dec 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
6,505
EUR
(Valued at Dec 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
47,143
EUR
(Valued at Dec 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
500
EUR
(Valued at Dec 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2023
6,092
EUR
(Valued at Nov 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
418
EUR
(Valued at Nov 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
95
EUR
(Valued at Nov 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
40,603
EUR
(Valued at Nov 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
111
EUR
(Valued at Nov 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
4,357
EUR
(Valued at Nov 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,000
EUR
(Valued at Nov 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,080
EUR
(Valued at Nov 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
3,000
EUR
(Valued at Nov 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,110
EUR
(Valued at Nov 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
900
EUR
(Valued at Nov 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
20,756
EUR
(Valued at Nov 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
43,286
EUR
(Valued at Nov 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
3,350
EUR
(Valued at Nov 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,773
EUR
(Valued at Nov 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
37,009
EUR
(Valued at Nov 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,433
EUR
(Valued at Nov 30, 2023)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
20,066
EUR
(Valued at Nov 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
33,320
EUR
(Valued at Nov 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
35,823
EUR
(Valued at Nov 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,405
EUR
(Valued at Nov 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
2,913
EUR
(Valued at Nov 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
6,422
EUR
(Valued at Nov 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,747
EUR
(Valued at Nov 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
3,421
EUR
(Valued at Nov 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
4,853
EUR
(Valued at Nov 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
5,209
EUR
(Valued at Nov 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
12,404
EUR
(Valued at Nov 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
7,602
EUR
(Valued at Nov 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
2,528
EUR
(Valued at Nov 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
3,311
EUR
(Valued at Nov 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
662
EUR
(Valued at Nov 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
928
EUR
(Valued at Nov 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,927
EUR
(Valued at Nov 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
4,350
EUR
(Valued at Nov 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
7,315
EUR
(Valued at Nov 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
256
EUR
(Valued at Nov 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,210
EUR
(Valued at Nov 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
373
EUR
(Valued at Nov 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
24,391
EUR
(Valued at Nov 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
5,404
EUR
(Valued at Nov 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
9,804
EUR
(Valued at Nov 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
534
EUR
(Valued at Nov 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
78,651
EUR
(Valued at Nov 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
42,548
EUR
(Valued at Nov 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
613
EUR
(Valued at Nov 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,336
EUR
(Valued at Nov 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,060
EUR
(Valued at Nov 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
19,794
EUR
(Valued at Nov 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
4,248
EUR
(Valued at Nov 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,218
EUR
(Valued at Nov 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
1,828
EUR
(Valued at Nov 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2023
14,854
EUR
(Valued at Oct 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
9,200
EUR
(Valued at Oct 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
655
EUR
(Valued at Oct 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
4,189
EUR
(Valued at Oct 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
1,910
EUR
(Valued at Oct 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
675
EUR
(Valued at Oct 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
450
EUR
(Valued at Oct 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
18,349
EUR
(Valued at Oct 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
273
EUR
(Valued at Oct 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
598
EUR
(Valued at Oct 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
600
EUR
(Valued at Oct 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
1,952
EUR
(Valued at Oct 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
655
EUR
(Valued at Oct 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
183,747
EUR
(Valued at Oct 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
46,084
EUR
(Valued at Oct 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
621
EUR
(Valued at Oct 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
1,347
EUR
(Valued at Oct 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
15,837
EUR
(Valued at Oct 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
4,642
EUR
(Valued at Oct 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
8,867
EUR
(Valued at Oct 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
8,389
EUR
(Valued at Oct 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
4,849
EUR
(Valued at Oct 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
302
EUR
(Valued at Oct 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
112
EUR
(Valued at Oct 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
1,019
EUR
(Valued at Oct 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
5,356
EUR
(Valued at Oct 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
75
EUR
(Valued at Oct 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
7,520
EUR
(Valued at Oct 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
1,600
EUR
(Valued at Oct 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
15,295
EUR
(Valued at Oct 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
2,030
EUR
(Valued at Oct 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
47
EUR
(Valued at Oct 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
3,000
EUR
(Valued at Oct 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
1,515
EUR
(Valued at Oct 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
37,735
EUR
(Valued at Oct 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
43,984
EUR
(Valued at Oct 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
3,333
EUR
(Valued at Oct 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
10,886
EUR
(Valued at Oct 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
47,650
EUR
(Valued at Oct 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
1,426
EUR
(Valued at Oct 31, 2023)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
48,034
EUR
(Valued at Oct 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
31,519
EUR
(Valued at Oct 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
37,240
EUR
(Valued at Oct 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
4,739
EUR
(Valued at Oct 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
12,182
EUR
(Valued at Oct 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
3
EUR
(Valued at Oct 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
4,278
EUR
(Valued at Oct 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
11,680
EUR
(Valued at Oct 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
5,230
EUR
(Valued at Oct 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
2,380
EUR
(Valued at Oct 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
28,928
EUR
(Valued at Oct 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2023
2,473
EUR
(Valued at Sep 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
3,121
EUR
(Valued at Sep 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
6,118
EUR
(Valued at Sep 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
2,789
EUR
(Valued at Sep 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
5,800
EUR
(Valued at Sep 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
51,858
EUR
(Valued at Sep 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
272
EUR
(Valued at Sep 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
745
EUR
(Valued at Sep 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
6
EUR
(Valued at Sep 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
875
EUR
(Valued at Sep 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
167,546
EUR
(Valued at Sep 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
4,794
EUR
(Valued at Sep 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
46,628
EUR
(Valued at Sep 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
150,360
EUR
(Valued at Sep 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
616
EUR
(Valued at Sep 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
1,343
EUR
(Valued at Sep 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
13,015
EUR
(Valued at Sep 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
16,218
EUR
(Valued at Sep 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
4,373
EUR
(Valued at Sep 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
7,408
EUR
(Valued at Sep 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
4,681
EUR
(Valued at Sep 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
307
EUR
(Valued at Sep 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
504
EUR
(Valued at Sep 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
4,193
EUR
(Valued at Sep 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
56,494
EUR
(Valued at Sep 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
1,265
EUR
(Valued at Sep 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
8,322
EUR
(Valued at Sep 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
1,460
EUR
(Valued at Sep 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
4,558
EUR
(Valued at Sep 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
1,384
EUR
(Valued at Sep 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
1,734
EUR
(Valued at Sep 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
2,140
EUR
(Valued at Sep 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
28,389
EUR
(Valued at Sep 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
38,639
EUR
(Valued at Sep 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
40,951
EUR
(Valued at Sep 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
6,671
EUR
(Valued at Sep 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
1,448
EUR
(Valued at Sep 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
26,391
EUR
(Valued at Sep 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
1,428
EUR
(Valued at Sep 30, 2023)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
1,449
EUR
(Valued at Sep 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
58,726
EUR
(Valued at Sep 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
148,462
EUR
(Valued at Sep 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
53
EUR
(Valued at Sep 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
3,350
EUR
(Valued at Sep 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
10,667
EUR
(Valued at Sep 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
2,344
EUR
(Valued at Sep 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
1,809
EUR
(Valued at Sep 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
10,548
EUR
(Valued at Sep 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
5,331
EUR
(Valued at Sep 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
2,341
EUR
(Valued at Sep 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
370
EUR
(Valued at Sep 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
-1,370
EUR
(Valued at Sep 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2023
11,403
EUR
(Valued at Aug 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
6,507
EUR
(Valued at Aug 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
2,273
EUR
(Valued at Aug 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
2
EUR
(Valued at Aug 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
3,503
EUR
(Valued at Aug 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
4,337
EUR
(Valued at Aug 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
1,863
EUR
(Valued at Aug 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
10,608
EUR
(Valued at Aug 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
265
EUR
(Valued at Aug 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
184
EUR
(Valued at Aug 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
193
EUR
(Valued at Aug 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
16,506
EUR
(Valued at Aug 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
3,148
EUR
(Valued at Aug 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
2,239
EUR
(Valued at Aug 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
437
EUR
(Valued at Aug 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
3,898
EUR
(Valued at Aug 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
44,194
EUR
(Valued at Aug 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
4,216
EUR
(Valued at Aug 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
621
EUR
(Valued at Aug 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
1,346
EUR
(Valued at Aug 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
18,715
EUR
(Valued at Aug 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
121,140
EUR
(Valued at Aug 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
8,306
EUR
(Valued at Aug 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
337
EUR
(Valued at Aug 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
5,453
EUR
(Valued at Aug 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
300
EUR
(Valued at Aug 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
31,829
EUR
(Valued at Aug 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
360
EUR
(Valued at Aug 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
117
EUR
(Valued at Aug 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
224
EUR
(Valued at Aug 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
7,980
EUR
(Valued at Aug 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
980
EUR
(Valued at Aug 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
10,063
EUR
(Valued at Aug 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
6,030
EUR
(Valued at Aug 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
4,133
EUR
(Valued at Aug 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
12,834
EUR
(Valued at Aug 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
37,845
EUR
(Valued at Aug 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
6,622
EUR
(Valued at Aug 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
1,438
EUR
(Valued at Aug 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
28,046
EUR
(Valued at Aug 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
1,418
EUR
(Valued at Aug 31, 2023)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
35,835
EUR
(Valued at Aug 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
26,988
EUR
(Valued at Aug 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
31,517
EUR
(Valued at Aug 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
1,460
EUR
(Valued at Aug 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
6,666
EUR
(Valued at Aug 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
6,609
EUR
(Valued at Aug 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
2,947
EUR
(Valued at Aug 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
2,784
EUR
(Valued at Aug 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
4,932
EUR
(Valued at Aug 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
5,582
EUR
(Valued at Aug 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
8,123
EUR
(Valued at Aug 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
3,126
EUR
(Valued at Aug 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2023
2,054
EUR
(Valued at Jul 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
1,229
EUR
(Valued at Jul 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
2
EUR
(Valued at Jul 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
977
EUR
(Valued at Jul 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
5,936
EUR
(Valued at Jul 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
3,130
EUR
(Valued at Jul 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
1,894
EUR
(Valued at Jul 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
33,756
EUR
(Valued at Jul 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
28,423
EUR
(Valued at Jul 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
535
EUR
(Valued at Jul 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
275
EUR
(Valued at Jul 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
186
EUR
(Valued at Jul 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
194
EUR
(Valued at Jul 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
2,383
EUR
(Valued at Jul 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
3,584
EUR
(Valued at Jul 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
2,284
EUR
(Valued at Jul 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
170,468
EUR
(Valued at Jul 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
1,876
EUR
(Valued at Jul 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
631
EUR
(Valued at Jul 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
1,372
EUR
(Valued at Jul 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
14,870
EUR
(Valued at Jul 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
7,531
EUR
(Valued at Jul 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
3,194
EUR
(Valued at Jul 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
4,682
EUR
(Valued at Jul 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
8,590
EUR
(Valued at Jul 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
136
EUR
(Valued at Jul 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
965
EUR
(Valued at Jul 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
11,732
EUR
(Valued at Jul 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
233
EUR
(Valued at Jul 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
3,667
EUR
(Valued at Jul 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
9,766
EUR
(Valued at Jul 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
1,416
EUR
(Valued at Jul 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
29,841
EUR
(Valued at Jul 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
7,317
EUR
(Valued at Jul 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
1,650
EUR
(Valued at Jul 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
26,814
EUR
(Valued at Jul 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
1,320
EUR
(Valued at Jul 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
2,750
EUR
(Valued at Jul 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
7,707
EUR
(Valued at Jul 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
27,082
EUR
(Valued at Jul 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
38,062
EUR
(Valued at Jul 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
-24,326
EUR
(Valued at Jul 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
286
EUR
(Valued at Jul 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
-14,954
EUR
(Valued at Jul 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
-3,722
EUR
(Valued at Jul 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
23,884
EUR
(Valued at Jul 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
37,442
EUR
(Valued at Jul 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
427
EUR
(Valued at Jul 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
9,379
EUR
(Valued at Jul 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
12,529
EUR
(Valued at Jul 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
5,754
EUR
(Valued at Jul 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
11,658
EUR
(Valued at Jul 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
3,714
EUR
(Valued at Jul 31, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
4,166
EUR
(Valued at Jul 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
1,614
EUR
(Valued at Jul 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2023
4
EUR
(Valued at Jun 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
1,212
EUR
(Valued at Jun 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
886
EUR
(Valued at Jun 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
2,467
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
1,619
EUR
(Valued at Jun 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
6,185
EUR
(Valued at Jun 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
290
EUR
(Valued at Jun 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
192
EUR
(Valued at Jun 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
2,415
EUR
(Valued at Jun 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
79,673
EUR
(Valued at Jun 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
396
EUR
(Valued at Jun 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
151,633
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
1,418
EUR
(Valued at Jun 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
651
EUR
(Valued at Jun 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
4,800
EUR
(Valued at Jun 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
19,418
EUR
(Valued at Jun 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
3,476
EUR
(Valued at Jun 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
4,927
EUR
(Valued at Jun 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
1,054
EUR
(Valued at Jun 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
321
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
507
EUR
(Valued at Jun 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
803
EUR
(Valued at Jun 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
1,057
EUR
(Valued at Jun 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
864
EUR
(Valued at Jun 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
19,554
EUR
(Valued at Jun 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
2,000
EUR
(Valued at Jun 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
18,847
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
3,600
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
28,315
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
2,750
EUR
(Valued at Jun 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
1,100
EUR
(Valued at Jun 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
3,850
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
1,381
EUR
(Valued at Jun 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
28,011
EUR
(Valued at Jun 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
43,486
EUR
(Valued at Jun 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
2,717
EUR
(Valued at Jun 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
57,684
EUR
(Valued at Jun 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
24,485
EUR
(Valued at Jun 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
196
EUR
(Valued at Jun 30, 2023)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
138,377
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
9,416
EUR
(Valued at Jun 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
52
EUR
(Valued at Jun 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
93,150
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
2,108
EUR
(Valued at Jun 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
4,174
EUR
(Valued at Jun 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
9,362
EUR
(Valued at Jun 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
7,103
EUR
(Valued at Jun 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
3,944
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
9,357
EUR
(Valued at Jun 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
41,997
EUR
(Valued at Jun 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2023
29,468
EUR
(Valued at May 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
3,417
EUR
(Valued at May 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
9,658
EUR
(Valued at May 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
1,418
EUR
(Valued at May 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
1,855
EUR
(Valued at May 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
3
EUR
(Valued at May 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
265
EUR
(Valued at May 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
203
EUR
(Valued at May 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
104,576
EUR
(Valued at May 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
2,848
EUR
(Valued at May 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
3,593
EUR
(Valued at May 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
70
EUR
(Valued at May 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
56,606
EUR
(Valued at May 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
1,441
EUR
(Valued at May 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
667
EUR
(Valued at May 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
12,282
EUR
(Valued at May 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
9,718
EUR
(Valued at May 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
3,710
EUR
(Valued at May 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
659
EUR
(Valued at May 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
349
EUR
(Valued at May 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
805
EUR
(Valued at May 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
219
EUR
(Valued at May 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
17,244
EUR
(Valued at May 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
752
EUR
(Valued at May 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
821
EUR
(Valued at May 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
2,824
EUR
(Valued at May 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
2,750
EUR
(Valued at May 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
4,070
EUR
(Valued at May 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
1,010
EUR
(Valued at May 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
41,631
EUR
(Valued at May 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
9,315
EUR
(Valued at May 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
7,811
EUR
(Valued at May 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
58,383
EUR
(Valued at May 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
16,432
EUR
(Valued at May 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
33,919
EUR
(Valued at May 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
2,548
EUR
(Valued at May 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
2,197
EUR
(Valued at May 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
8,231
EUR
(Valued at May 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
7,442
EUR
(Valued at May 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
5,405
EUR
(Valued at May 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
10,279
EUR
(Valued at May 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2023
3,801
EUR
(Valued at Apr 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
504
EUR
(Valued at Apr 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
11
EUR
(Valued at Apr 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
5,046
EUR
(Valued at Apr 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
18,413
EUR
(Valued at Apr 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
1,904
EUR
(Valued at Apr 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
840
EUR
(Valued at Apr 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
236
EUR
(Valued at Apr 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
219
EUR
(Valued at Apr 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
195
EUR
(Valued at Apr 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
3,931
EUR
(Valued at Apr 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
12,653
EUR
(Valued at Apr 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
44,821
EUR
(Valued at Apr 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
1,441
EUR
(Valued at Apr 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
653
EUR
(Valued at Apr 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
20,689
EUR
(Valued at Apr 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
4,990
EUR
(Valued at Apr 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
4,038
EUR
(Valued at Apr 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
652
EUR
(Valued at Apr 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
1
EUR
(Valued at Apr 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
60
EUR
(Valued at Apr 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
6,809
EUR
(Valued at Apr 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
4,761
EUR
(Valued at Apr 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
57,771
EUR
(Valued at Apr 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
350
EUR
(Valued at Apr 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
14,223
EUR
(Valued at Apr 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
8,453
EUR
(Valued at Apr 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
1,000
EUR
(Valued at Apr 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
5,280
EUR
(Valued at Apr 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
1,320
EUR
(Valued at Apr 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
11,358
EUR
(Valued at Apr 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
38,059
EUR
(Valued at Apr 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
5,931
EUR
(Valued at Apr 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
5,412
EUR
(Valued at Apr 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
73,494
EUR
(Valued at Apr 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
27,726
EUR
(Valued at Apr 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
28,771
EUR
(Valued at Apr 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
46,165
EUR
(Valued at Apr 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
2,052
EUR
(Valued at Apr 30, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
2,168
EUR
(Valued at Apr 30, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
8,834
EUR
(Valued at Apr 30, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
6,192
EUR
(Valued at Apr 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
3,489
EUR
(Valued at Apr 30, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
8,120
EUR
(Valued at Apr 30, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
96,040
EUR
(Valued at Apr 30, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
12,540
EUR
(Valued at Apr 30, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2023
11,403
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
4,835
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
2,554
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
4,246
EUR
(Valued at Mar 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
3,052
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
1,896
EUR
(Valued at Mar 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
39,413
EUR
(Valued at Mar 31, 2023)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
764
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
158
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
154
EUR
(Valued at Mar 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
484
EUR
(Valued at Mar 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
17,151
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
102,061
EUR
(Valued at Mar 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
5,367
EUR
(Valued at Mar 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
142,573
EUR
(Valued at Mar 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
437
EUR
(Valued at Mar 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
1,448
EUR
(Valued at Mar 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
273,990
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
170
EUR
(Valued at Mar 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
511
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
4,800
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
10,833
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
14,643
EUR
(Valued at Mar 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
12,961
EUR
(Valued at Mar 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
831
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
388
EUR
(Valued at Mar 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
632
EUR
(Valued at Mar 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
81,302
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
200
EUR
(Valued at Mar 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
1,242
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
1,560
EUR
(Valued at Mar 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
50,884
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
1,688
EUR
(Valued at Mar 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
36,405
EUR
(Valued at Mar 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
7,775
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
370
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
1,111
EUR
(Valued at Mar 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
3,098
EUR
(Valued at Mar 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
47,514
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
120,343
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
6,152
EUR
(Valued at Mar 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
5,829
EUR
(Valued at Mar 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
1,449
EUR
(Valued at Mar 31, 2023)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
46,620
EUR
(Valued at Mar 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
-14,771
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
24,844
EUR
(Valued at Mar 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
1,354
EUR
(Valued at Mar 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
4,190
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
7,035
EUR
(Valued at Mar 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
2,178
EUR
(Valued at Mar 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
4,853
EUR
(Valued at Mar 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
5,347
EUR
(Valued at Mar 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
2,249
EUR
(Valued at Mar 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
2,055
EUR
(Valued at Mar 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
210,340
EUR
(Valued at Mar 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2023
651
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
18
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
28,801
EUR
(Valued at Feb 28, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
6,094
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
1,815
EUR
(Valued at Feb 28, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
8,008
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
1,110
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
166
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
150
EUR
(Valued at Feb 28, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
1,098
EUR
(Valued at Feb 28, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
-2,321
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
5,273
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
347
EUR
(Valued at Feb 28, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
39,152
EUR
(Valued at Feb 28, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
1,410
EUR
(Valued at Feb 28, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
646
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
16,019
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
10,005
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
4,403
EUR
(Valued at Feb 28, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
3,637
EUR
(Valued at Feb 28, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
862
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
1,967
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
511
EUR
(Valued at Feb 28, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
3,903
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
675
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
360
EUR
(Valued at Feb 28, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
765
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
4,919
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
662
EUR
(Valued at Feb 28, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
1,041
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
19,093
EUR
(Valued at Feb 28, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
100,649
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
6,699
EUR
(Valued at Feb 28, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
9,579
EUR
(Valued at Feb 28, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
1,403
EUR
(Valued at Feb 28, 2023)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
32,062
EUR
(Valued at Feb 28, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
46,089
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
23,971
EUR
(Valued at Feb 28, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
4,844
EUR
(Valued at Feb 28, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
3,670
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
7,354
EUR
(Valued at Feb 28, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
2,120
EUR
(Valued at Feb 28, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
6,440
EUR
(Valued at Feb 28, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
6,006
EUR
(Valued at Feb 28, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
2,161
EUR
(Valued at Feb 28, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
2,087
EUR
(Valued at Feb 28, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
4,019
EUR
(Valued at Feb 28, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2023
18
EUR
(Valued at Jan 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
12
EUR
(Valued at Jan 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
4,211
EUR
(Valued at Jan 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
2,628
EUR
(Valued at Jan 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
1,880
EUR
(Valued at Jan 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
708
EUR
(Valued at Jan 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
179
EUR
(Valued at Jan 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
158
EUR
(Valued at Jan 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
245
EUR
(Valued at Jan 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
-13
EUR
(Valued at Jan 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
1,967
EUR
(Valued at Jan 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
26,792
EUR
(Valued at Jan 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
4,082
EUR
(Valued at Jan 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
47,988
EUR
(Valued at Jan 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
-12,056
EUR
(Valued at Jan 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
1,384
EUR
(Valued at Jan 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
631
EUR
(Valued at Jan 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
-1,167
EUR
(Valued at Jan 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
7,312
EUR
(Valued at Jan 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
30,618
EUR
(Valued at Jan 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
-2,827
EUR
(Valued at Jan 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
320
EUR
(Valued at Jan 31, 2023)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
23,363
EUR
(Valued at Jan 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
827
EUR
(Valued at Jan 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
-31,164
EUR
(Valued at Jan 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
1,119
EUR
(Valued at Jan 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
259
EUR
(Valued at Jan 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
1,264
EUR
(Valued at Jan 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
9,186
EUR
(Valued at Jan 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
990
EUR
(Valued at Jan 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
20,905
EUR
(Valued at Jan 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
1,384
EUR
(Valued at Jan 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
60
EUR
(Valued at Jan 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
4,500
EUR
(Valued at Jan 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
500
EUR
(Valued at Jan 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
900
EUR
(Valued at Jan 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
152,848
EUR
(Valued at Jan 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
7,355
EUR
(Valued at Jan 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
9,584
EUR
(Valued at Jan 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
1,668
EUR
(Valued at Jan 31, 2023)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
38,619
EUR
(Valued at Jan 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
43,282
EUR
(Valued at Jan 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
23,312
EUR
(Valued at Jan 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
-80,369
EUR
(Valued at Jan 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
2,634
EUR
(Valued at Jan 31, 2023)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
7,764
EUR
(Valued at Jan 31, 2023)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
2,132
EUR
(Valued at Jan 31, 2023)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
5,083
EUR
(Valued at Jan 31, 2023)
Norad - Norwegian Agency for Development Cooperation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
6,243
EUR
(Valued at Jan 31, 2023)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
5,395
EUR
(Valued at Jan 31, 2023)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
-15,909
EUR
(Valued at Jan 31, 2023)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2023
75,571
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
15,946
EUR
(Valued at Dec 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
145
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
9,674
EUR
(Valued at Dec 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
17,635
EUR
(Valued at Dec 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
3,874
EUR
(Valued at Dec 31, 2022)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
5,600
EUR
(Valued at Dec 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
4,044
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
1,025
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
764
EUR
(Valued at Dec 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
79
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
79
EUR
(Valued at Dec 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
13
EUR
(Valued at Dec 31, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
120,547
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
5,432
EUR
(Valued at Dec 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
160,478
EUR
(Valued at Dec 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
-919
EUR
(Valued at Dec 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
175,045
EUR
(Valued at Dec 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
10,106
EUR
(Valued at Dec 31, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
45,245
EUR
(Valued at Dec 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
1,167
EUR
(Valued at Dec 31, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
972
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
4,800
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
135,760
EUR
(Valued at Dec 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
54,393
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
304
EUR
(Valued at Dec 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
27,252
EUR
(Valued at Dec 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
20,274
EUR
(Valued at Dec 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
21,056
EUR
(Valued at Dec 31, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
27,298
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
9,075
EUR
(Valued at Dec 31, 2022)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
6,331
EUR
(Valued at Dec 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
7,589
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
90
EUR
(Valued at Dec 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
8,482
EUR
(Valued at Dec 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
22,787
EUR
(Valued at Dec 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
9,708
EUR
(Valued at Dec 31, 2022)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
5,133
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
8,048
EUR
(Valued at Dec 31, 2022)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
238,930
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
7,677
EUR
(Valued at Dec 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
11,724
EUR
(Valued at Dec 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
10,533
EUR
(Valued at Dec 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
30,607
EUR
(Valued at Dec 31, 2022)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
14,179
EUR
(Valued at Dec 31, 2022)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
154,654
EUR
(Valued at Dec 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
11,439
EUR
(Valued at Dec 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
105,358
EUR
(Valued at Dec 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
128,402
EUR
(Valued at Dec 31, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
7
EUR
(Valued at Dec 31, 2022)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
5,963
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
9,058
EUR
(Valued at Dec 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
10,350
EUR
(Valued at Dec 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
19,961
EUR
(Valued at Dec 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
186
EUR
(Valued at Dec 31, 2022)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
11,096
EUR
(Valued at Dec 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
7,629
EUR
(Valued at Dec 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
16
EUR
(Valued at Dec 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
18,075
EUR
(Valued at Dec 31, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
38,452
EUR
(Valued at Dec 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2022
17,139
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
9,173
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
7,655
EUR
(Valued at Nov 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
8,000
EUR
(Valued at Nov 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
44,892
EUR
(Valued at Nov 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
55
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
55
EUR
(Valued at Nov 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
12,689
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
2,719
EUR
(Valued at Nov 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
38,103
EUR
(Valued at Nov 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
34
EUR
(Valued at Nov 30, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
6,196
EUR
(Valued at Nov 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
-23,628
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
90,648
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
10,342
EUR
(Valued at Nov 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
25,467
EUR
(Valued at Nov 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
886
EUR
(Valued at Nov 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
90,375
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
1,500
EUR
(Valued at Nov 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
3,520
EUR
(Valued at Nov 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
1,957
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
1,591
EUR
(Valued at Nov 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
22,959
EUR
(Valued at Nov 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
425
EUR
(Valued at Nov 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
5,500
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
17,935
EUR
(Valued at Nov 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
177,382
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
13,909
EUR
(Valued at Nov 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
14,053
EUR
(Valued at Nov 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
101
EUR
(Valued at Nov 30, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
35,334
EUR
(Valued at Nov 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
8,104
EUR
(Valued at Nov 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
7,276
EUR
(Valued at Nov 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
2,918
EUR
(Valued at Nov 30, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
876
EUR
(Valued at Nov 30, 2022)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
3,840
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
7,184
EUR
(Valued at Nov 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
9,468
EUR
(Valued at Nov 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
5,956
EUR
(Valued at Nov 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
5,075
EUR
(Valued at Nov 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
7,926
EUR
(Valued at Nov 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
621
EUR
(Valued at Nov 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
7,316
EUR
(Valued at Nov 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2022
766
EUR
(Valued at Oct 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
3,000
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
7,690
EUR
(Valued at Oct 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
3,000
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
57
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
57
EUR
(Valued at Oct 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
14,959
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
2,717
EUR
(Valued at Oct 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
631
EUR
(Valued at Oct 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
32,840
EUR
(Valued at Oct 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
5
EUR
(Valued at Oct 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
1,964
EUR
(Valued at Oct 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
272
EUR
(Valued at Oct 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
9,425
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
32,089
EUR
(Valued at Oct 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
32,471
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
21,630
EUR
(Valued at Oct 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
5,674
EUR
(Valued at Oct 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
20,352
EUR
(Valued at Oct 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
42,117
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
750
EUR
(Valued at Oct 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
1,259
EUR
(Valued at Oct 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
11,218
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
671
EUR
(Valued at Oct 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
2,500
EUR
(Valued at Oct 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
8,254
EUR
(Valued at Oct 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
883
EUR
(Valued at Oct 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
5,600
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
1,414
EUR
(Valued at Oct 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
39,579
EUR
(Valued at Oct 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
155,219
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
15,601
EUR
(Valued at Oct 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
11,195
EUR
(Valued at Oct 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
42,642
EUR
(Valued at Oct 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
8,240
EUR
(Valued at Oct 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
9,005
EUR
(Valued at Oct 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
2,967
EUR
(Valued at Oct 31, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
3,843
EUR
(Valued at Oct 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
7,425
EUR
(Valued at Oct 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
10,135
EUR
(Valued at Oct 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
7,870
EUR
(Valued at Oct 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
4,614
EUR
(Valued at Oct 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2022
7,602
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
15,388
EUR
(Valued at Sep 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
31
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
9,172
EUR
(Valued at Sep 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
19,343
EUR
(Valued at Sep 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
1,144
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
768
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
56
EUR
(Valued at Sep 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
3,883
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
297
EUR
(Valued at Sep 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
158,179
EUR
(Valued at Sep 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
12,519
EUR
(Valued at Sep 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
2,675
EUR
(Valued at Sep 30, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
116,928
EUR
(Valued at Sep 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
2,008
EUR
(Valued at Sep 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
24,959
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
11,283
EUR
(Valued at Sep 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
9,174
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
2,410
EUR
(Valued at Sep 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
14,785
EUR
(Valued at Sep 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
949
EUR
(Valued at Sep 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
65,802
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
1,000
EUR
(Valued at Sep 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
2,000
EUR
(Valued at Sep 30, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
4,335
EUR
(Valued at Sep 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
64,901
EUR
(Valued at Sep 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
1,843
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
3,044
EUR
(Valued at Sep 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
98,775
EUR
(Valued at Sep 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
4,358
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
29,517
EUR
(Valued at Sep 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
144,216
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
14,624
EUR
(Valued at Sep 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
17,719
EUR
(Valued at Sep 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
845
EUR
(Valued at Sep 30, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
534
EUR
(Valued at Sep 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
41,322
EUR
(Valued at Sep 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
10,320
EUR
(Valued at Sep 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
70,877
EUR
(Valued at Sep 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
2,949
EUR
(Valued at Sep 30, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
28
EUR
(Valued at Sep 30, 2022)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
3,919
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
157
EUR
(Valued at Sep 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
12,497
EUR
(Valued at Sep 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
381
EUR
(Valued at Sep 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
5,688
EUR
(Valued at Sep 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
7,972
EUR
(Valued at Sep 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
856
EUR
(Valued at Sep 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
188,957
EUR
(Valued at Sep 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
1,093
EUR
(Valued at Sep 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2022
1,425
EUR
(Valued at Aug 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
50
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
4,977
EUR
(Valued at Aug 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
1,029
EUR
(Valued at Aug 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
28,423
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
56
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
56
EUR
(Valued at Aug 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
8,722
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
18
EUR
(Valued at Aug 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
9,583
EUR
(Valued at Aug 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
2,688
EUR
(Valued at Aug 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
61,801
EUR
(Valued at Aug 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
1,983
EUR
(Valued at Aug 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
22,340
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
2,587
EUR
(Valued at Aug 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
30,662
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
133
EUR
(Valued at Aug 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
15,104
EUR
(Valued at Aug 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
940
EUR
(Valued at Aug 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
43,652
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
706
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
99,021
EUR
(Valued at Aug 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
457
EUR
(Valued at Aug 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
2,500
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
556
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
2,684
EUR
(Valued at Aug 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
1,112
EUR
(Valued at Aug 31, 2022)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
299
EUR
(Valued at Aug 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
2,352
EUR
(Valued at Aug 31, 2022)
Brian Mercer Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
140,880
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
14,516
EUR
(Valued at Aug 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
9,524
EUR
(Valued at Aug 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
1,508
EUR
(Valued at Aug 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
2,456
EUR
(Valued at Aug 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
45,120
EUR
(Valued at Aug 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
9,771
EUR
(Valued at Aug 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
28,010
EUR
(Valued at Aug 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
2,896
EUR
(Valued at Aug 31, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
4,729
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
8
EUR
(Valued at Aug 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
13,201
EUR
(Valued at Aug 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
121
EUR
(Valued at Aug 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
2,939
EUR
(Valued at Aug 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
4,350
EUR
(Valued at Aug 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
8,632
EUR
(Valued at Aug 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
6,920
EUR
(Valued at Aug 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2022
-25,274
EUR
(Valued at Jul 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
3,865
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
179,276
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
14,093
EUR
(Valued at Jul 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
13,321
EUR
(Valued at Jul 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
1,561
EUR
(Valued at Jul 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
5,565
EUR
(Valued at Jul 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
41,948
EUR
(Valued at Jul 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
9,682
EUR
(Valued at Jul 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
25,400
EUR
(Valued at Jul 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
2,791
EUR
(Valued at Jul 31, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
3,135
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
11,894
EUR
(Valued at Jul 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
645
EUR
(Valued at Jul 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
5,035
EUR
(Valued at Jul 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
8,533
EUR
(Valued at Jul 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
2,921
EUR
(Valued at Jul 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
20,459
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
7,602
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
262
EUR
(Valued at Jul 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
11
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
1,851
EUR
(Valued at Jul 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
3,010
EUR
(Valued at Jul 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
5,600
EUR
(Valued at Jul 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
1,000
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
10,490
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
55
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
1
EUR
(Valued at Jul 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
54
EUR
(Valued at Jul 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
510
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
514
EUR
(Valued at Jul 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
150
EUR
(Valued at Jul 31, 2022)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
18,306
EUR
(Valued at Jul 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
2,613
EUR
(Valued at Jul 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
3,786
EUR
(Valued at Jul 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
43,734
EUR
(Valued at Jul 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
1,922
EUR
(Valued at Jul 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
769
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
220
EUR
(Valued at Jul 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
8,835
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
36,235
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
427
EUR
(Valued at Jul 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
5,418
EUR
(Valued at Jul 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
925
EUR
(Valued at Jul 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
303,159
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
11,200
EUR
(Valued at Jul 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
5,000
EUR
(Valued at Jul 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
5,670
EUR
(Valued at Jul 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
5,375
EUR
(Valued at Jul 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2022
27,880
EUR
(Valued at Jun 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
3,467
EUR
(Valued at Jun 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
9,483
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
4,827
EUR
(Valued at Jun 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
3,072
EUR
(Valued at Jun 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
3,000
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
55
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
0
EUR
(Valued at Jun 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
55
EUR
(Valued at Jun 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
8,370
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
34,612
EUR
(Valued at Jun 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
72,304
EUR
(Valued at Jun 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
2,633
EUR
(Valued at Jun 30, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
115,846
EUR
(Valued at Jun 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
28,435
EUR
(Valued at Jun 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
21,171
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
395,986
EUR
(Valued at Jun 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
747
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
-1,656
EUR
(Valued at Jun 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
4,051
EUR
(Valued at Jun 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
902
EUR
(Valued at Jun 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
9,198
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
2,500
EUR
(Valued at Jun 30, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
32,361
EUR
(Valued at Jun 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
235
EUR
(Valued at Jun 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
10,107
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
132,938
EUR
(Valued at Jun 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
51,373
EUR
(Valued at Jun 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
28,315
EUR
(Valued at Jun 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
4,922
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
30,000
EUR
(Valued at Jun 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
44,569
EUR
(Valued at Jun 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
125,474
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
22,390
EUR
(Valued at Jun 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
12,298
EUR
(Valued at Jun 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
7,875
EUR
(Valued at Jun 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
6,891
EUR
(Valued at Jun 30, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
50,112
EUR
(Valued at Jun 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
10,213
EUR
(Valued at Jun 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
67,267
EUR
(Valued at Jun 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
4,030
EUR
(Valued at Jun 30, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
3,486
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
3
EUR
(Valued at Jun 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
11,669
EUR
(Valued at Jun 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
59
EUR
(Valued at Jun 30, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
1,169
EUR
(Valued at Jun 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
5,414
EUR
(Valued at Jun 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
8,297
EUR
(Valued at Jun 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
3,793
EUR
(Valued at Jun 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
116
EUR
(Valued at Jun 30, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
13,890
EUR
(Valued at Jun 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2022
29,067
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
27,880
EUR
(Valued at May 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
1,532
EUR
(Valued at May 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
29
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
1,810
EUR
(Valued at May 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
7,893
EUR
(Valued at May 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
3,065
EUR
(Valued at May 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
2,100
EUR
(Valued at May 31, 2022)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
56,967
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
10,769
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
27,131
EUR
(Valued at May 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
55
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
1
EUR
(Valued at May 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
54
EUR
(Valued at May 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
950
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
17,488
EUR
(Valued at May 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
5,106
EUR
(Valued at May 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
2,595
EUR
(Valued at May 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
32,319
EUR
(Valued at May 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
2,023
EUR
(Valued at May 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
12,990
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
34,020
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
5,832
EUR
(Valued at May 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
10,853
EUR
(Valued at May 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
902
EUR
(Valued at May 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
4,285
EUR
(Valued at May 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
100,965
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
2,000
EUR
(Valued at May 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
6,854
EUR
(Valued at May 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
2,314
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
108,517
EUR
(Valued at May 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
3,960
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
2,059
EUR
(Valued at May 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
129,930
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
23,708
EUR
(Valued at May 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
8,380
EUR
(Valued at May 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
7,154
EUR
(Valued at May 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
3,517
EUR
(Valued at May 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
47,167
EUR
(Valued at May 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
39,000
EUR
(Valued at May 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
9,836
EUR
(Valued at May 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
4,091
EUR
(Valued at May 31, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
3,736
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
7
EUR
(Valued at May 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
9,310
EUR
(Valued at May 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
84
EUR
(Valued at May 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
643
EUR
(Valued at May 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
5,721
EUR
(Valued at May 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
8,594
EUR
(Valued at May 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
20,322
EUR
(Valued at May 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
90
EUR
(Valued at May 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2022
223
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
4,377
EUR
(Valued at Apr 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
2,319
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
9,084
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
3,430
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
7,772
EUR
(Valued at Apr 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
9,092
EUR
(Valued at Apr 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
1,285
EUR
(Valued at Apr 30, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
18
EUR
(Valued at Apr 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
28,410
EUR
(Valued at Apr 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
2,122
EUR
(Valued at Apr 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
1,200
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
263,366
EUR
(Valued at Apr 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
14,580
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
419
EUR
(Valued at Apr 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
5,544
EUR
(Valued at Apr 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
916
EUR
(Valued at Apr 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
5,529
EUR
(Valued at Apr 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
5,158
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
11,200
EUR
(Valued at Apr 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
1,500
EUR
(Valued at Apr 30, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
3,347
EUR
(Valued at Apr 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
1,868
EUR
(Valued at Apr 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
19,086
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
225,500
EUR
(Valued at Apr 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
25,487
EUR
(Valued at Apr 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
3,675
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
119,479
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
23,112
EUR
(Valued at Apr 30, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
7,092
EUR
(Valued at Apr 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
7,052
EUR
(Valued at Apr 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
3,742
EUR
(Valued at Apr 30, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
40,319
EUR
(Valued at Apr 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
10,539
EUR
(Valued at Apr 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
9,274
EUR
(Valued at Apr 30, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
4,077
EUR
(Valued at Apr 30, 2022)
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
2,845
EUR
(Valued at Apr 30, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
9,516
EUR
(Valued at Apr 30, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
614
EUR
(Valued at Apr 30, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
7,417
EUR
(Valued at Apr 30, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
16,080
EUR
(Valued at Apr 30, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2022
2,226
EUR
(Valued at Mar 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
10,582
EUR
(Valued at Mar 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
1,516
EUR
(Valued at Mar 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
20,000
EUR
(Valued at Mar 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
5,176
EUR
(Valued at Mar 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
73,915
EUR
(Valued at Mar 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
5,871
EUR
(Valued at Mar 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
3,257
EUR
(Valued at Mar 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
66,765
EUR
(Valued at Mar 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
65,732
EUR
(Valued at Mar 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
1,256
EUR
(Valued at Mar 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
1,858
EUR
(Valued at Mar 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
76,898
EUR
(Valued at Mar 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
704,412
EUR
(Valued at Mar 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
1,344
EUR
(Valued at Mar 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
43,530
EUR
(Valued at Mar 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
112,776
EUR
(Valued at Mar 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
6,916
EUR
(Valued at Mar 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
418
EUR
(Valued at Mar 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
889
EUR
(Valued at Mar 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
77,536
EUR
(Valued at Mar 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
3,228
EUR
(Valued at Mar 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
326
EUR
(Valued at Mar 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
22,400
EUR
(Valued at Mar 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
2,750
EUR
(Valued at Mar 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
1,313
EUR
(Valued at Mar 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
792
EUR
(Valued at Mar 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
66,094
EUR
(Valued at Mar 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
36,405
EUR
(Valued at Mar 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
287
EUR
(Valued at Mar 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
3,365
EUR
(Valued at Mar 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
18,177
EUR
(Valued at Mar 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
115,337
EUR
(Valued at Mar 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
74
EUR
(Valued at Mar 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
51,011
EUR
(Valued at Mar 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
22,066
EUR
(Valued at Mar 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
77,459
EUR
(Valued at Mar 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
4,121
EUR
(Valued at Mar 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
41,527
EUR
(Valued at Mar 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
18,423
EUR
(Valued at Mar 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
11,326
EUR
(Valued at Mar 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
2,898
EUR
(Valued at Mar 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
8,404
EUR
(Valued at Mar 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
1,302
EUR
(Valued at Mar 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
4,229
EUR
(Valued at Mar 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
18,406
EUR
(Valued at Mar 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
16,661
EUR
(Valued at Mar 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2022
90,685
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
2,852
EUR
(Valued at Feb 28, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
268
EUR
(Valued at Feb 28, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
1,612
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
277
EUR
(Valued at Feb 28, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
5,400
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
13,701
EUR
(Valued at Feb 28, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
1,314
EUR
(Valued at Feb 28, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
14,687
EUR
(Valued at Feb 28, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
1,329
EUR
(Valued at Feb 28, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
3,871
EUR
(Valued at Feb 28, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
20,836
EUR
(Valued at Feb 28, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
2,099
EUR
(Valued at Feb 28, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
307,760
EUR
(Valued at Feb 28, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
48,850
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
234
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
5,285
EUR
(Valued at Feb 28, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
440
EUR
(Valued at Feb 28, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
889
EUR
(Valued at Feb 28, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
5,704
EUR
(Valued at Feb 28, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
5,750
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
544
EUR
(Valued at Feb 28, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
1,000
EUR
(Valued at Feb 28, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
66,333
EUR
(Valued at Feb 28, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
2,186
EUR
(Valued at Feb 28, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
12,994
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
450
EUR
(Valued at Feb 28, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
1,098
EUR
(Valued at Feb 28, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
3,556
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
1,042
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
119,187
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
98
EUR
(Valued at Feb 28, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
6,569
EUR
(Valued at Feb 28, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
18,902
EUR
(Valued at Feb 28, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
7,409
EUR
(Valued at Feb 28, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
2,100
EUR
(Valued at Feb 28, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
30,413
EUR
(Valued at Feb 28, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
9,107
EUR
(Valued at Feb 28, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
13,260
EUR
(Valued at Feb 28, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
2,707
EUR
(Valued at Feb 28, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
7,764
EUR
(Valued at Feb 28, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
569
EUR
(Valued at Feb 28, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
3,942
EUR
(Valued at Feb 28, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
9,866
EUR
(Valued at Feb 28, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
2,153
EUR
(Valued at Feb 28, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2022
4,715
EUR
(Valued at Jan 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
-9,242
EUR
(Valued at Jan 31, 2022)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
24,740
EUR
(Valued at Jan 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
22,123
EUR
(Valued at Jan 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
3,193
EUR
(Valued at Jan 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
15,370
EUR
(Valued at Jan 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
2,186
EUR
(Valued at Jan 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
6,909
EUR
(Valued at Jan 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
1,000
EUR
(Valued at Jan 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
-744
EUR
(Valued at Jan 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
13,768
EUR
(Valued at Jan 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
-1,028
EUR
(Valued at Jan 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
40,267
EUR
(Valued at Jan 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
3,495
EUR
(Valued at Jan 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
2,781
EUR
(Valued at Jan 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
15,873
EUR
(Valued at Jan 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
2,111
EUR
(Valued at Jan 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
216
EUR
(Valued at Jan 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
54
EUR
(Valued at Jan 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
15,655
EUR
(Valued at Jan 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
-8,154
EUR
(Valued at Jan 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
-5,284
EUR
(Valued at Jan 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
2,004
EUR
(Valued at Jan 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
-929
EUR
(Valued at Jan 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
873
EUR
(Valued at Jan 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
2,642
EUR
(Valued at Jan 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
2,827
EUR
(Valued at Jan 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
1,011
EUR
(Valued at Jan 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
750
EUR
(Valued at Jan 31, 2022)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
79,952
EUR
(Valued at Jan 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
27,875
EUR
(Valued at Jan 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
2,625
EUR
(Valued at Jan 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
23,214
EUR
(Valued at Jan 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
3,382
EUR
(Valued at Jan 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
120,718
EUR
(Valued at Jan 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
3,651
EUR
(Valued at Jan 31, 2022)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
4,879
EUR
(Valued at Jan 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
4,086
EUR
(Valued at Jan 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
6,060
EUR
(Valued at Jan 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
10,994
EUR
(Valued at Jan 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
12,952
EUR
(Valued at Jan 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
8,812
EUR
(Valued at Jan 31, 2022)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
1,497
EUR
(Valued at Jan 31, 2022)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
7,620
EUR
(Valued at Jan 31, 2022)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
-6,148
EUR
(Valued at Jan 31, 2022)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
366
EUR
(Valued at Jan 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
1,651
EUR
(Valued at Jan 31, 2022)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
11,420
EUR
(Valued at Jan 31, 2022)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
1,547
EUR
(Valued at Jan 31, 2022)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2022
3,232
EUR
(Valued at Dec 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
1,229
EUR
(Valued at Dec 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
12,977
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
25,400
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
10,500
EUR
(Valued at Dec 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
62,969
EUR
(Valued at Dec 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
37
EUR
(Valued at Dec 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
163,150
EUR
(Valued at Dec 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
2,663
EUR
(Valued at Dec 31, 2021)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
124,052
EUR
(Valued at Dec 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
1,488
EUR
(Valued at Dec 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
123
EUR
(Valued at Dec 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
1,566
EUR
(Valued at Dec 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
24,288
EUR
(Valued at Dec 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
9,624
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
16,753
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
12,316
EUR
(Valued at Dec 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
8,580
EUR
(Valued at Dec 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
36,269
EUR
(Valued at Dec 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
3,101
EUR
(Valued at Dec 31, 2021)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
889
EUR
(Valued at Dec 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
8,396
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
12,246
EUR
(Valued at Dec 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
174
EUR
(Valued at Dec 31, 2021)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
25,114
EUR
(Valued at Dec 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
59,835
EUR
(Valued at Dec 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
106,316
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
31,733
EUR
(Valued at Dec 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
26,058
EUR
(Valued at Dec 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
1,446
EUR
(Valued at Dec 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
304
EUR
(Valued at Dec 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
32,432
EUR
(Valued at Dec 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
4,811
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
10,926
EUR
(Valued at Dec 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
311,726
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
917
EUR
(Valued at Dec 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
5,044
EUR
(Valued at Dec 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
11,173
EUR
(Valued at Dec 31, 2021)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
70,335
EUR
(Valued at Dec 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
36,276
EUR
(Valued at Dec 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
97,516
EUR
(Valued at Dec 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
37,884
EUR
(Valued at Dec 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
22,321
EUR
(Valued at Dec 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
58,767
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
1,031,575
EUR
(Valued at Dec 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
63,527
EUR
(Valued at Dec 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
2,846
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
12,292
EUR
(Valued at Dec 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
2,799
EUR
(Valued at Dec 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
14,035
EUR
(Valued at Dec 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
639
EUR
(Valued at Dec 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
10,187
EUR
(Valued at Dec 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
6,120
EUR
(Valued at Dec 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
5,268
EUR
(Valued at Dec 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
9,913
EUR
(Valued at Dec 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
1,273
EUR
(Valued at Dec 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
41
EUR
(Valued at Dec 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2021
3,834
EUR
(Valued at Nov 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
18,572
EUR
(Valued at Nov 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
74
EUR
(Valued at Nov 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
30,441
EUR
(Valued at Nov 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
20,762
EUR
(Valued at Nov 30, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
49
EUR
(Valued at Nov 30, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
13,651
EUR
(Valued at Nov 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
242,275
EUR
(Valued at Nov 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
232,040
EUR
(Valued at Nov 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
4,138
EUR
(Valued at Nov 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
20,545
EUR
(Valued at Nov 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
3,999
EUR
(Valued at Nov 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
895
EUR
(Valued at Nov 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
874
EUR
(Valued at Nov 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
40,068
EUR
(Valued at Nov 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
1,695
EUR
(Valued at Nov 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
26,860
EUR
(Valued at Nov 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
13,220
EUR
(Valued at Nov 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
12,067
EUR
(Valued at Nov 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
53,724
EUR
(Valued at Nov 30, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
2,214
EUR
(Valued at Nov 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
94,916
EUR
(Valued at Nov 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
2,682
EUR
(Valued at Nov 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
13,001
EUR
(Valued at Nov 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
628
EUR
(Valued at Nov 30, 2021)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
4,168
EUR
(Valued at Nov 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
7,997
EUR
(Valued at Nov 30, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
41,394
EUR
(Valued at Nov 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
3,568
EUR
(Valued at Nov 30, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
6,219
EUR
(Valued at Nov 30, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
629,831
EUR
(Valued at Nov 30, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
826
EUR
(Valued at Nov 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
310
EUR
(Valued at Nov 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
7,915
EUR
(Valued at Nov 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
7,426
EUR
(Valued at Nov 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
389
EUR
(Valued at Nov 30, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
2,381
EUR
(Valued at Nov 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
267
EUR
(Valued at Nov 30, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
7,103
EUR
(Valued at Nov 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
2,153
EUR
(Valued at Nov 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
600
EUR
(Valued at Nov 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Nov 30, 2021
2,530
EUR
(Valued at Oct 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
154
EUR
(Valued at Oct 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
10,253
EUR
(Valued at Oct 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
6,610
EUR
(Valued at Oct 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
18,978
EUR
(Valued at Oct 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
1,346
EUR
(Valued at Oct 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
10,334
EUR
(Valued at Oct 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
1,720
EUR
(Valued at Oct 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
1,200
EUR
(Valued at Oct 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
37,773
EUR
(Valued at Oct 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
806
EUR
(Valued at Oct 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
4,082
EUR
(Valued at Oct 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
11,822
EUR
(Valued at Oct 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
874
EUR
(Valued at Oct 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
76,446
EUR
(Valued at Oct 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
1,989
EUR
(Valued at Oct 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
77,939
EUR
(Valued at Oct 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
115,099
EUR
(Valued at Oct 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
36,338
EUR
(Valued at Oct 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
2,122
EUR
(Valued at Oct 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
1,954
EUR
(Valued at Oct 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
2,207
EUR
(Valued at Oct 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
82,366
EUR
(Valued at Oct 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
1,767
EUR
(Valued at Oct 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
623
EUR
(Valued at Oct 31, 2021)
Switzerland - Swiss Agency for Development and Cooperation (SDC)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
1,043
EUR
(Valued at Oct 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
7,575
EUR
(Valued at Oct 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
894
EUR
(Valued at Oct 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
33,445
EUR
(Valued at Oct 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
7,064
EUR
(Valued at Oct 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
3,141
EUR
(Valued at Oct 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
1,256
EUR
(Valued at Oct 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
10,147
EUR
(Valued at Oct 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
6,525
EUR
(Valued at Oct 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
4,876
EUR
(Valued at Oct 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
800
EUR
(Valued at Oct 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
750
EUR
(Valued at Oct 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
2,512
EUR
(Valued at Oct 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
124,613
EUR
(Valued at Oct 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Oct 31, 2021
4,296
EUR
(Valued at Sep 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
15,950
EUR
(Valued at Sep 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
2,047
EUR
(Valued at Sep 30, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
640
EUR
(Valued at Sep 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
76,870
EUR
(Valued at Sep 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
9,345
EUR
(Valued at Sep 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
32,848
EUR
(Valued at Sep 30, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
1,119
EUR
(Valued at Sep 30, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
10,805
EUR
(Valued at Sep 30, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
125,722
EUR
(Valued at Sep 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
5,694
EUR
(Valued at Sep 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
1,062
EUR
(Valued at Sep 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
3,449
EUR
(Valued at Sep 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
677
EUR
(Valued at Sep 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
58,248
EUR
(Valued at Sep 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
1,865
EUR
(Valued at Sep 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
41,745
EUR
(Valued at Sep 30, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
2,771
EUR
(Valued at Sep 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
131,604
EUR
(Valued at Sep 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
339
EUR
(Valued at Sep 30, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
14,010
EUR
(Valued at Sep 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
1,330
EUR
(Valued at Sep 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
1,262
EUR
(Valued at Sep 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
10,193
EUR
(Valued at Sep 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
91,615
EUR
(Valued at Sep 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
5,600
EUR
(Valued at Sep 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
6,160
EUR
(Valued at Sep 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
1,679
EUR
(Valued at Sep 30, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
546
EUR
(Valued at Sep 30, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
42,416
EUR
(Valued at Sep 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
25,922
EUR
(Valued at Sep 30, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
5
EUR
(Valued at Sep 30, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
1,367
EUR
(Valued at Sep 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
21,708
EUR
(Valued at Sep 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
3,909
EUR
(Valued at Sep 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
14,946
EUR
(Valued at Sep 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
4,067
EUR
(Valued at Sep 30, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
5,767
EUR
(Valued at Sep 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
80,752
EUR
(Valued at Sep 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Sep 30, 2021
2,462
EUR
(Valued at Aug 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
5,760
EUR
(Valued at Aug 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
20,583
EUR
(Valued at Aug 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
12,932
EUR
(Valued at Aug 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
10,423
EUR
(Valued at Aug 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
36,253
EUR
(Valued at Aug 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
1,885
EUR
(Valued at Aug 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
1,277
EUR
(Valued at Aug 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
306,840
EUR
(Valued at Aug 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
151,216
EUR
(Valued at Aug 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
3,513
EUR
(Valued at Aug 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
1,462
EUR
(Valued at Aug 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
3,696
EUR
(Valued at Aug 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
40
EUR
(Valued at Aug 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
633
EUR
(Valued at Aug 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
149,345
EUR
(Valued at Aug 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
1,688
EUR
(Valued at Aug 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
152,046
EUR
(Valued at Aug 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
23
EUR
(Valued at Aug 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
36,124
EUR
(Valued at Aug 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
935
EUR
(Valued at Aug 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
1,273
EUR
(Valued at Aug 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
20,641
EUR
(Valued at Aug 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
1,682
EUR
(Valued at Aug 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
8,247
EUR
(Valued at Aug 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
77,658
EUR
(Valued at Aug 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
2,117
EUR
(Valued at Aug 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
14,260
EUR
(Valued at Aug 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
8,227
EUR
(Valued at Aug 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
902
EUR
(Valued at Aug 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
44,669
EUR
(Valued at Aug 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
13,394
EUR
(Valued at Aug 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
8,010
EUR
(Valued at Aug 31, 2021)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
3,443
EUR
(Valued at Aug 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
14,164
EUR
(Valued at Aug 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
3,897
EUR
(Valued at Aug 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
896
EUR
(Valued at Aug 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
678
EUR
(Valued at Aug 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
1,280
EUR
(Valued at Aug 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
5,299
EUR
(Valued at Aug 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
85
EUR
(Valued at Aug 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
12,381
EUR
(Valued at Aug 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Aug 31, 2021
4,020
EUR
(Valued at Jul 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
397
EUR
(Valued at Jul 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
630
EUR
(Valued at Jul 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
5,077
EUR
(Valued at Jul 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
228
EUR
(Valued at Jul 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
18,815
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
2,400
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
2,416
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
3,734
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
8,641
EUR
(Valued at Jul 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
8,641
EUR
(Valued at Jul 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
9,143
EUR
(Valued at Jul 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
13,023
EUR
(Valued at Jul 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
7,772
EUR
(Valued at Jul 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
28,319
EUR
(Valued at Jul 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
1,917
EUR
(Valued at Jul 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
4,748
EUR
(Valued at Jul 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
298
EUR
(Valued at Jul 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
1,200
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
9,181
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
964
EUR
(Valued at Jul 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
3,964
EUR
(Valued at Jul 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
100
EUR
(Valued at Jul 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
208,246
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
1,962
EUR
(Valued at Jul 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
13,915
EUR
(Valued at Jul 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
4,472
EUR
(Valued at Jul 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
6,225
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
408
EUR
(Valued at Jul 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
26,750
EUR
(Valued at Jul 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
1,663
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
10,828
EUR
(Valued at Jul 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
87,696
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
-6,659
EUR
(Valued at Jul 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
14,164
EUR
(Valued at Jul 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
4,078
EUR
(Valued at Jul 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
806
EUR
(Valued at Jul 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
32,631
EUR
(Valued at Jul 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
44,689
EUR
(Valued at Jul 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
9,308
EUR
(Valued at Jul 31, 2021)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
2,670
EUR
(Valued at Jul 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
14,538
EUR
(Valued at Jul 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jul 31, 2021
13,722
EUR
(Valued at Jun 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
1,869
EUR
(Valued at Jun 30, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
1,822
EUR
(Valued at Jun 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
118,918
EUR
(Valued at Jun 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
33,463
EUR
(Valued at Jun 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
2,419
EUR
(Valued at Jun 30, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
44,839
EUR
(Valued at Jun 30, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
5,802
EUR
(Valued at Jun 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
6,173
EUR
(Valued at Jun 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
2,282
EUR
(Valued at Jun 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
2,610
EUR
(Valued at Jun 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
2,924
EUR
(Valued at Jun 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
9,649
EUR
(Valued at Jun 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
2,365
EUR
(Valued at Jun 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
121,329
EUR
(Valued at Jun 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
22,273
EUR
(Valued at Jun 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
5,774
EUR
(Valued at Jun 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
4,484
EUR
(Valued at Jun 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
91,302
EUR
(Valued at Jun 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
5,879
EUR
(Valued at Jun 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
16,009
EUR
(Valued at Jun 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
7,448
EUR
(Valued at Jun 30, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
33,651
EUR
(Valued at Jun 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
13,909
EUR
(Valued at Jun 30, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
8,379
EUR
(Valued at Jun 30, 2021)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
2,343
EUR
(Valued at Jun 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
10,986
EUR
(Valued at Jun 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
4,525
EUR
(Valued at Jun 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
2,394
EUR
(Valued at Jun 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
4,875
EUR
(Valued at Jun 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
3,380
EUR
(Valued at Jun 30, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
122,621
EUR
(Valued at Jun 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
1,700
EUR
(Valued at Jun 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jun 30, 2021
1,380
EUR
(Valued at May 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
37,515
EUR
(Valued at May 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
773
EUR
(Valued at May 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
1,945
EUR
(Valued at May 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
3,775
EUR
(Valued at May 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
1,537
EUR
(Valued at May 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
11,647
EUR
(Valued at May 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
873
EUR
(Valued at May 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
27,567
EUR
(Valued at May 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
23,025
EUR
(Valued at May 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
183
EUR
(Valued at May 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
3,216
EUR
(Valued at May 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
2,652
EUR
(Valued at May 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
2,894
EUR
(Valued at May 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
5,521
EUR
(Valued at May 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
1,821
EUR
(Valued at May 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
85,599
EUR
(Valued at May 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
15,077
EUR
(Valued at May 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
11,950
EUR
(Valued at May 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
25,111
EUR
(Valued at May 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
71,746
EUR
(Valued at May 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
52,772
EUR
(Valued at May 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
14,990
EUR
(Valued at May 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
6,959
EUR
(Valued at May 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
30,985
EUR
(Valued at May 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
13,172
EUR
(Valued at May 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
7,210
EUR
(Valued at May 31, 2021)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
1,167
EUR
(Valued at May 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
9,913
EUR
(Valued at May 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
5,245
EUR
(Valued at May 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
19,516
EUR
(Valued at May 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
5,033
EUR
(Valued at May 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
2,365
EUR
(Valued at May 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
12,978
EUR
(Valued at May 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
May 31, 2021
3,041
EUR
(Valued at Apr 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
1,572
EUR
(Valued at Apr 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
13,407
EUR
(Valued at Apr 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
7,867
EUR
(Valued at Apr 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
9,712
EUR
(Valued at Apr 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
93
EUR
(Valued at Apr 30, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
9,475
EUR
(Valued at Apr 30, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
40,441
EUR
(Valued at Apr 30, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
239,630
EUR
(Valued at Apr 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
10,502
EUR
(Valued at Apr 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
3,250
EUR
(Valued at Apr 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
2,845
EUR
(Valued at Apr 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
4,126
EUR
(Valued at Apr 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
-22
EUR
(Valued at Apr 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
3,338
EUR
(Valued at Apr 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
1,576
EUR
(Valued at Apr 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
17,566
EUR
(Valued at Apr 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
24,865
EUR
(Valued at Apr 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
1,389
EUR
(Valued at Apr 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
10,668
EUR
(Valued at Apr 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
11,201
EUR
(Valued at Apr 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
70,753
EUR
(Valued at Apr 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
18,731
EUR
(Valued at Apr 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
18,005
EUR
(Valued at Apr 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
34,506
EUR
(Valued at Apr 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
19,973
EUR
(Valued at Apr 30, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
6,659
EUR
(Valued at Apr 30, 2021)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
1,069
EUR
(Valued at Apr 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
2,313
EUR
(Valued at Apr 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
3,543
EUR
(Valued at Apr 30, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
5,838
EUR
(Valued at Apr 30, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
3,859
EUR
(Valued at Apr 30, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
3,037
EUR
(Valued at Apr 30, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
34,339
EUR
(Valued at Apr 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
425
EUR
(Valued at Apr 30, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
1,161
EUR
(Valued at Apr 30, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
1,806
EUR
(Valued at Apr 30, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Apr 30, 2021
106,367
EUR
(Valued at Mar 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
11
EUR
(Valued at Mar 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
2,273
EUR
(Valued at Mar 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
6,906
EUR
(Valued at Mar 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
2,977
EUR
(Valued at Mar 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
162
EUR
(Valued at Mar 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
61,212
EUR
(Valued at Mar 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
6,897
EUR
(Valued at Mar 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
2,186
EUR
(Valued at Mar 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
38,938
EUR
(Valued at Mar 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
112,111
EUR
(Valued at Mar 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
71,791
EUR
(Valued at Mar 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
223,600
EUR
(Valued at Mar 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
2,692
EUR
(Valued at Mar 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
14,053
EUR
(Valued at Mar 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
2,332
EUR
(Valued at Mar 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
169
EUR
(Valued at Mar 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
52
EUR
(Valued at Mar 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
357,359
EUR
(Valued at Mar 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
1,896
EUR
(Valued at Mar 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
325,700
EUR
(Valued at Mar 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
5,099
EUR
(Valued at Mar 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
8,300
EUR
(Valued at Mar 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
5,053
EUR
(Valued at Mar 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
58,863
EUR
(Valued at Mar 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
39,968
EUR
(Valued at Mar 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
1,743
EUR
(Valued at Mar 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
22,862
EUR
(Valued at Mar 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
10,196
EUR
(Valued at Mar 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
3,094
EUR
(Valued at Mar 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
581
EUR
(Valued at Mar 31, 2021)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
1,440
EUR
(Valued at Mar 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
11,799
EUR
(Valued at Mar 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
3,813
EUR
(Valued at Mar 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
-1,272
EUR
(Valued at Mar 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
2,209
EUR
(Valued at Mar 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
1,235
EUR
(Valued at Mar 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
12,038
EUR
(Valued at Mar 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
2,153
EUR
(Valued at Mar 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
3,311
EUR
(Valued at Mar 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
450
EUR
(Valued at Mar 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
625
EUR
(Valued at Mar 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
3,060
EUR
(Valued at Mar 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Mar 31, 2021
166
EUR
(Valued at Feb 28, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
-1,104
EUR
(Valued at Feb 28, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
27,840
EUR
(Valued at Feb 28, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
309
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
103
EUR
(Valued at Feb 28, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
23,391
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
-258
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
7,046
EUR
(Valued at Feb 28, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
3,544
EUR
(Valued at Feb 28, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
180
EUR
(Valued at Feb 28, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
2,839
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
1,440
EUR
(Valued at Feb 28, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
23
EUR
(Valued at Feb 28, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
3,864
EUR
(Valued at Feb 28, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
23
EUR
(Valued at Feb 28, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
3,000
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
431
EUR
(Valued at Feb 28, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
25,610
EUR
(Valued at Feb 28, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
57,883
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
42,751
EUR
(Valued at Feb 28, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
1,572
EUR
(Valued at Feb 28, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
5,209
EUR
(Valued at Feb 28, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
21,914
EUR
(Valued at Feb 28, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
8,816
EUR
(Valued at Feb 28, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
3,071
EUR
(Valued at Feb 28, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
3
EUR
(Valued at Feb 28, 2021)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
1,463
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
23,088
EUR
(Valued at Feb 28, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
3,494
EUR
(Valued at Feb 28, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
-1,799
EUR
(Valued at Feb 28, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
4,398
EUR
(Valued at Feb 28, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
1,100
EUR
(Valued at Feb 28, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
2,153
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
8,345
EUR
(Valued at Feb 28, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
2,250
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
156
EUR
(Valued at Feb 28, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
5,499
EUR
(Valued at Feb 28, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
1,015
EUR
(Valued at Feb 28, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
2,839
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
32
EUR
(Valued at Feb 28, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
291
EUR
(Valued at Feb 28, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
10,215
EUR
(Valued at Feb 28, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
61
EUR
(Valued at Feb 28, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Feb 28, 2021
4,560
EUR
(Valued at Jan 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
2,533
EUR
(Valued at Jan 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
54
EUR
(Valued at Jan 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
31
EUR
(Valued at Jan 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
20,545
EUR
(Valued at Jan 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
782
EUR
(Valued at Jan 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
1,136
EUR
(Valued at Jan 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
162
EUR
(Valued at Jan 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
32,995
EUR
(Valued at Jan 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
-13,599
EUR
(Valued at Jan 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
145
EUR
(Valued at Jan 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
114
EUR
(Valued at Jan 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
34,310
EUR
(Valued at Jan 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
16
EUR
(Valued at Jan 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
311
EUR
(Valued at Jan 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
2,850
EUR
(Valued at Jan 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
45,370
EUR
(Valued at Jan 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
-6,008
EUR
(Valued at Jan 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
3,569
EUR
(Valued at Jan 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
165
EUR
(Valued at Jan 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
3,926
EUR
(Valued at Jan 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
1,089
EUR
(Valued at Jan 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
23
EUR
(Valued at Jan 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
7,040
EUR
(Valued at Jan 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
20,000
EUR
(Valued at Jan 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
44,803
EUR
(Valued at Jan 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
48,570
EUR
(Valued at Jan 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
-6,224
EUR
(Valued at Jan 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
135
EUR
(Valued at Jan 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
11,613
EUR
(Valued at Jan 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
11,866
EUR
(Valued at Jan 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
9,451
EUR
(Valued at Jan 31, 2021)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
-14,015
EUR
(Valued at Jan 31, 2021)
private donor
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
-3,723
EUR
(Valued at Jan 31, 2021)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
-44,896
EUR
(Valued at Jan 31, 2021)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
5,616
EUR
(Valued at Jan 31, 2021)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
-2,724
EUR
(Valued at Jan 31, 2021)
Netherlands - Ministry of Foreign Affairs
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
-4,885
EUR
(Valued at Jan 31, 2021)
Médecins Sans Frontières Switzerland
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
45
EUR
(Valued at Jan 31, 2021)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
-11,714
EUR
(Valued at Jan 31, 2021)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
-4,212
EUR
(Valued at Jan 31, 2021)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Jan 31, 2021
222
EUR
(Valued at Dec 31, 2020)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
2,000
EUR
(Valued at Dec 31, 2020)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
2,112
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
24
EUR
(Valued at Dec 31, 2020)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
5,191
EUR
(Valued at Dec 31, 2020)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
106,281
EUR
(Valued at Dec 31, 2020)
Federal Ministry of Education and Research (BMBF) through KfW, Germany
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
335
EUR
(Valued at Dec 31, 2020)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
2,706
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
3,198
EUR
(Valued at Dec 31, 2020)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
12,372
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
300
EUR
(Valued at Dec 31, 2020)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
14,657
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
1,950
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
3,546
EUR
(Valued at Dec 31, 2020)
blank
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
349,591
EUR
(Valued at Dec 31, 2020)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
13,235
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
24,005
EUR
(Valued at Dec 31, 2020)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
-3,173
EUR
(Valued at Dec 31, 2020)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
3,045
EUR
(Valued at Dec 31, 2020)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
939
EUR
(Valued at Dec 31, 2020)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
584,381
EUR
(Valued at Dec 31, 2020)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
3,300
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
1,257
EUR
(Valued at Dec 31, 2020)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
54,969
EUR
(Valued at Dec 31, 2020)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
2,618
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
12,660
EUR
(Valued at Dec 31, 2020)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
276,953
EUR
(Valued at Dec 31, 2020)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
6,313
EUR
(Valued at Dec 31, 2020)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
12,891
EUR
(Valued at Dec 31, 2020)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
3,098
EUR
(Valued at Dec 31, 2020)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
750
EUR
(Valued at Dec 31, 2020)
European and Developing Countries Clinical Trials Partnership Association (EDCTP)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
1,333
EUR
(Valued at Dec 31, 2020)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
122
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
5,372
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
4,678
EUR
(Valued at Dec 31, 2020)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
327,870
EUR
(Valued at Dec 31, 2020)
Wellcome Trust, UK
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
80,853
EUR
(Valued at Dec 31, 2020)
UK - Department for International Development (DFID)
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
23,195
EUR
(Valued at Dec 31, 2020)
Takeda Pharmaceutical Company Limited, Japan
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
25,251
EUR
(Valued at Dec 31, 2020)
Médecins sans Frontières
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
49,897
EUR
(Valued at Dec 31, 2020)
Medicor Foundation
Drugs for Neglected Diseases initiative
Expenditure
date_range
Dec 31, 2020
116,020
EUR
(Valued at Dec 31, 2020)
Global Health Innovative Technology Fund (GHIT Fund), Japan
Drugs for Neglected Diseases initiative
